Table 3.
Receptor (PKCδ Clb) | Ki (nM) on l0% PS | Relative to l00% PS | Ki (nM) on 30% PS | Relative to l00% PS | Ki (nM) on l00% PS | No. of positive charges |
---|---|---|---|---|---|---|
K26Y | 213 ±31 | 2 x | 67.9 ± 1.3 | 0.64 x | 106 ± 25 | 0 |
WT | 63.3 ± 16.3 | 12 x | 11.1 ± 1.7 | 2.1 x | 5.3 ± 0.6 | 1 |
Sl0R | 62.7 ± 4.9 | 17 x | 12.5 ± 1.0 | 3.4 x | 3.7 ± 0.9 | 2 |
N7R | 791 ± 80 | 36 x | 55.2 ± 4.8 | 2.5 x | 21.8 ± 0.7 | 2 |
W22R | 11873 ± 2754 | 169 x | 470 ± 74 | 6.7 x | 70.1 ±15.9 | 2 |
S10RW22R | 3113 ± 948 | 133 x | 126 ±18 | 5.5 x | 23.4 ± 2.9 | 3 |
N7RW22R | 20432 ± 3133 | 11 x | 983 ± 64 | 0.5 x | 1807 ± 103 | 3 |
The binding affinities of DOG to purified wild-type and mutant GST-PKCδ C1b domains were measured in the presence of the indicated proportions of PS in PS/PC phospholipid mixtures at a fixed total phospholipid concentration of 100 μg/ml. The Ki value relative to that in 100% PS is displayed. The number of positive charges in the binding cleft of each mutant is also shown. Values shown are the means ± SEM for n = 3 experiments.